Transforming effective patient recruitment within the changing health care landscape

Patient recruitment continues to be a significant hurdle for drug developers bringing new therapies to market. As health care behavior shifts toward a digital-first world, sponsors must adapt to an environment where patients expect accessibility, personalization and seamless, tech-enabled interactions across their health care journeys.

The PPD™ clinical research business of Thermo Fisher Scientific addresses these challenges through a patient-first recruitment and retention model that leverages real-world data, AI and ML-driven insights, point-of-care data-driven targeting, community networks and registries, and adaptive digital outreach to identify, understand and engage patients where they already are. This integrated, data-activated and empathy-driven approach ensures more precise, scalable and meaningful patient connections, accelerating enrollment and improving study outcomes.

Explore how advanced data and technology are transforming effective patient recruitment by downloading the white paper.